Global OTC Anti-Infective Drug Market Insights, Forecast to 2028

Table Of Contents

1 Report Business Overview

1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global OTC Anti-Infective Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Antifungal 1.2.3 Antibacterial 1.2.4 Antiviral 1.2.5 Antiseptics 1.2.6 Other 1.3 Market by Application 1.3.1 Global OTC Anti-Infective Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospital Pharmacies 1.3.3 Retail Pharmacies 1.3.4 Online Pharmacies 1.4 Study Objectives 1.5 Years Considered2 Global Growth Trends 2.1 Global OTC Anti-Infective Drug Market Perspective (2017-2028) 2.2 OTC Anti-Infective Drug Growth Trends by Region 2.2.1 OTC Anti-Infective Drug Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 OTC Anti-Infective Drug Historic Market Size by Region (2017-2022) 2.2.3 OTC Anti-Infective Drug Forecasted Market Size by Region (2023-2028) 2.3 OTC Anti-Infective Drug Market Dynamics 2.3.1 OTC Anti-Infective Drug Industry Trends 2.3.2 OTC Anti-Infective Drug Market Drivers 2.3.3 OTC Anti-Infective Drug Market Challenges 2.3.4 OTC Anti-Infective Drug Market Restraints3 Competition Landscape by Key Players 3.1 Global Top OTC Anti-Infective Drug Players by Revenue 3.1.1 Global Top OTC Anti-Infective Drug Players by Revenue (2017-2022) 3.1.2 Global OTC Anti-Infective Drug Revenue Market Share by Players (2017-2022) 3.2 Global OTC Anti-Infective Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by OTC Anti-Infective Drug Revenue 3.4 Global OTC Anti-Infective Drug Market Concentration Ratio 3.4.1 Global OTC Anti-Infective Drug Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by OTC Anti-Infective Drug Revenue in 2021 3.5 OTC Anti-Infective Drug Key Players Head office and Area Served 3.6 Key Players OTC Anti-Infective Drug Product Solution and Service 3.7 Date of Enter into OTC Anti-Infective Drug Market 3.8 Mergers & Acquisitions, Expansion Plans4 OTC Anti-Infective Drug Breakdown Data by Type 4.1 Global OTC Anti-Infective Drug Historic Market Size by Type (2017-2022) 4.2 Global OTC Anti-Infective Drug Forecasted Market Size by Type (2023-2028)5 OTC Anti-Infective Drug Breakdown Data by Application 5.1 Global OTC Anti-Infective Drug Historic Market Size by Application (2017-2022) 5.2 Global OTC Anti-Infective Drug Forecasted Market Size by Application (2023-2028)6 North America 6.1 North America OTC Anti-Infective Drug Market Size (2017-2028) 6.2 North America OTC Anti-Infective Drug Market Size by Type 6.2.1 North America OTC Anti-Infective Drug Market Size by Type (2017-2022) 6.2.2 North America OTC Anti-Infective Drug Market Size by Type (2023-2028) 6.2.3 North America OTC Anti-Infective Drug Market Share by Type (2017-2028) 6.3 North America OTC Anti-Infective Drug Market Size by Application 6.3.1 North America OTC Anti-Infective Drug Market Size by Application (2017-2022) 6.3.2 North America OTC Anti-Infective Drug Market Size by Application (2023-2028) 6.3.3 North America OTC Anti-Infective Drug Market Share by Application (2017-2028) 6.4 North America OTC Anti-Infective Drug Market Size by Country 6.4.1 North America OTC Anti-Infective Drug Market Size by Country (2017-2022) 6.4.2 North America OTC Anti-Infective Drug Market Size by Country (2023-2028) 6.4.3 United States 6.4.4 Canada7 Europe 7.1 Europe OTC Anti-Infective Drug Market Size (2017-2028) 7.2 Europe OTC Anti-Infective Drug Market Size by Type 7.2.1 Europe OTC Anti-Infective Drug Market Size by Type (2017-2022) 7.2.2 Europe OTC Anti-Infective Drug Market Size by Type (2023-2028) 7.2.3 Europe OTC Anti-Infective Drug Market Share by Type (2017-2028) 7.3 Europe OTC Anti-Infective Drug Market Size by Application 7.3.1 Europe OTC Anti-Infective Drug Market Size by Application (2017-2022) 7.3.2 Europe OTC Anti-Infective Drug Market Size by Application (2023-2028) 7.3.3 Europe OTC Anti-Infective Drug Market Share by Application (2017-2028) 7.4 Europe OTC Anti-Infective Drug Market Size by Country 7.4.1 Europe OTC Anti-Infective Drug Market Size by Country (2017-2022) 7.4.2 Europe OTC Anti-Infective Drug Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries8 Asia-Pacific 8.1 Asia-Pacific OTC Anti-Infective Drug Market Size (2017-2028) 8.2 Asia-Pacific OTC Anti-Infective Drug Market Size by Type 8.2.1 Asia-Pacific OTC Anti-Infective Drug Market Size by Type (2017-2022) 8.2.2 Asia-Pacific OTC Anti-Infective Drug Market Size by Type (2023-2028) 8.2.3 Asia-Pacific OTC Anti-Infective Drug Market Share by Type (2017-2028) 8.3 Asia-Pacific OTC Anti-Infective Drug Market Size by Application 8.3.1 Asia-Pacific OTC Anti-Infective Drug Market Size by Application (2017-2022) 8.3.2 Asia-Pacific OTC Anti-Infective Drug Market Size by Application (2023-2028) 8.3.3 Asia-Pacific OTC Anti-Infective Drug Market Share by Application (2017-2028) 8.4 Asia-Pacific OTC Anti-Infective Drug Market Size by Region 8.4.1 Asia-Pacific OTC Anti-Infective Drug Market Size by Region (2017-2022) 8.4.2 Asia-Pacific OTC Anti-Infective Drug Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America OTC Anti-Infective Drug Market Size (2017-2028) 9.2 Latin America OTC Anti-Infective Drug Market Size by Type 9.2.1 Latin America OTC Anti-Infective Drug Market Size by Type (2017-2022) 9.2.2 Latin America OTC Anti-Infective Drug Market Size by Type (2023-2028) 9.2.3 Latin America OTC Anti-Infective Drug Market Share by Type (2017-2028) 9.3 Latin America OTC Anti-Infective Drug Market Size by Application 9.3.1 Latin America OTC Anti-Infective Drug Market Size by Application (2017-2022) 9.3.2 Latin America OTC Anti-Infective Drug Market Size by Application (2023-2028) 9.3.3 Latin America OTC Anti-Infective Drug Market Share by Application (2017-2028) 9.4 Latin America OTC Anti-Infective Drug Market Size by Country 9.4.1 Latin America OTC Anti-Infective Drug Market Size by Country (2017-2022) 9.4.2 Latin America OTC Anti-Infective Drug Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil10 Middle East & Africa 10.1 Middle East & Africa OTC Anti-Infective Drug Market Size (2017-2028) 10.2 Middle East & Africa OTC Anti-Infective Drug Market Size by Type 10.2.1 Middle East & Africa OTC Anti-Infective Drug Market Size by Type (2017-2022) 10.2.2 Middle East & Africa OTC Anti-Infective Drug Market Size by Type (2023-2028) 10.2.3 Middle East & Africa OTC Anti-Infective Drug Market Share by Type (2017-2028) 10.3 Middle East & Africa OTC Anti-Infective Drug Market Size by Application 10.3.1 Middle East & Africa OTC Anti-Infective Drug Market Size by Application (2017-2022) 10.3.2 Middle East & Africa OTC Anti-Infective Drug Market Size by Application (2023-2028) 10.3.3 Middle East & Africa OTC Anti-Infective Drug Market Share by Application (2017-2028) 10.4 Middle East & Africa OTC Anti-Infective Drug Market Size by Country 10.4.1 Middle East & Africa OTC Anti-Infective Drug Market Size by Country (2017-2022) 10.4.2 Middle East & Africa OTC Anti-Infective Drug Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE11 Key Players Profiles 11.1 Bayer 11.1.1 Bayer Company Details 11.1.2 Bayer Business Overview 11.1.3 Bayer OTC Anti-Infective Drug Introduction 11.1.4 Bayer Revenue in OTC Anti-Infective Drug Business (2017-2022) 11.1.5 Bayer Recent Developments 11.2 GSK 11.2.1 GSK Company Details 11.2.2 GSK Business Overview 11.2.3 GSK OTC Anti-Infective Drug Introduction 11.2.4 GSK Revenue in OTC Anti-Infective Drug Business (2017-2022) 11.2.5 GSK Recent Developments 11.3 Teva 11.3.1 Teva Company Details 11.3.2 Teva Business Overview 11.3.3 Teva OTC Anti-Infective Drug Introduction 11.3.4 Teva Revenue in OTC Anti-Infective Drug Business (2017-2022) 11.3.5 Teva Recent Developments 11.4 Johnson & Johnson 11.4.1 Johnson & Johnson Company Details 11.4.2 Johnson & Johnson Business Overview 11.4.3 Johnson & Johnson OTC Anti-Infective Drug Introduction 11.4.4 Johnson & Johnson Revenue in OTC Anti-Infective Drug Business (2017-2022) 11.4.5 Johnson & Johnson Recent Developments 11.5 NOVARTIS 11.5.1 NOVARTIS Company Details 11.5.2 NOVARTIS Business Overview 11.5.3 NOVARTIS OTC Anti-Infective Drug Introduction 11.5.4 NOVARTIS Revenue in OTC Anti-Infective Drug Business (2017-2022) 11.5.5 NOVARTIS Recent Developments 11.6 MYLAN 11.6.1 MYLAN Company Details 11.6.2 MYLAN Business Overview 11.6.3 MYLAN OTC Anti-Infective Drug Introduction 11.6.4 MYLAN Revenue in OTC Anti-Infective Drug Business (2017-2022) 11.6.5 MYLAN Recent Developments 11.7 Sun Pharma 11.7.1 Sun Pharma Company Details 11.7.2 Sun Pharma Business Overview 11.7.3 Sun Pharma OTC Anti-Infective Drug Introduction 11.7.4 Sun Pharma Revenue in OTC Anti-Infective Drug Business (2017-2022) 11.7.5 Sun Pharma Recent Developments 11.8 CR SANJIU 11.8.1 CR SANJIU Company Details 11.8.2 CR SANJIU Business Overview 11.8.3 CR SANJIU OTC Anti-Infective Drug Introduction 11.8.4 CR SANJIU Revenue in OTC Anti-Infective Drug Business (2017-2022) 11.8.5 CR SANJIU Recent Developments 11.9 Cipla 11.9.1 Cipla Company Details 11.9.2 Cipla Business Overview 11.9.3 Cipla OTC Anti-Infective Drug Introduction 11.9.4 Cipla Revenue in OTC Anti-Infective Drug Business (2017-2022) 11.9.5 Cipla Recent Developments 11.10 Lingrui 11.10.1 Lingrui Company Details 11.10.2 Lingrui Business Overview 11.10.3 Lingrui OTC Anti-Infective Drug Introduction 11.10.4 Lingrui Revenue in OTC Anti-Infective Drug Business (2017-2022) 11.10.5 Lingrui Recent Developments12 Analyst's Viewpoints/Conclusions13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer